{"id":"low-dose-oliceridine","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Dizziness"},{"rate":null,"effect":"Vomiting"},{"rate":null,"effect":"Constipation"},{"rate":null,"effect":"Respiratory depression"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oliceridine binds to mu-opioid receptors in the central and peripheral nervous system to modulate pain signaling. The low-dose formulation is designed to achieve analgesic efficacy while minimizing respiratory depression, constipation, and other opioid-related side effects through biased signaling or reduced systemic exposure.","oneSentence":"Low-dose oliceridine is a selective mu-opioid receptor agonist that provides analgesia with potentially reduced adverse effects compared to standard-dose opioids.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:53:27.841Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain management"},{"name":"Postoperative pain"}]},"trialDetails":[{"nctId":"NCT07306702","phase":"PHASE4","title":"Dexmedetomidine-Enhanced PCIA After Lobectomy in Nicotine-Dependent Patients","status":"COMPLETED","sponsor":"Shenyang Sixth People's Hospital","startDate":"2023-07-01","conditions":"Postoperative Pain Management","enrollment":102},{"nctId":"NCT06320041","phase":"PHASE4","title":"Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery","status":"RECRUITING","sponsor":"The Fourth Affiliated Hospital of Zhejiang University School of Medicine","startDate":"2024-08-01","conditions":"Postoperative Pain","enrollment":162},{"nctId":"NCT06409689","phase":"NA","title":"Oliceridine-Enhanced Analgesia and Recovery: A G-Protein Biased μ-Opioid Study","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2024-06-01","conditions":"Postoperative Analgesia","enrollment":80},{"nctId":"NCT06619145","phase":"PHASE4","title":"1.Comparison of the Analgesic Effect of Remifentanil Group and Different Dose Groups of Oliceridine in Postoperative Patients Undergoing Cardiac Surgery 2.Exploring the Hemodynamic Effects of Analgesic Regimens With Different Doses of Oliceridine After Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Nanjing First Hospital, Nanjing Medical University","startDate":"2024-11-01","conditions":"Oliceridine, Postoperative Cardiac Surgery","enrollment":270}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Low dose Oliceridine","genericName":"Low dose Oliceridine","companyName":"Nanjing First Hospital, Nanjing Medical University","companyId":"nanjing-first-hospital-nanjing-medical-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Low-dose oliceridine is a selective mu-opioid receptor agonist that provides analgesia with potentially reduced adverse effects compared to standard-dose opioids. Used for Acute pain management, Postoperative pain.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}